German breast cancer DMP (disease management programme) sparks controversy
This article was originally published in Clinica
The leading groups of the German statutory health insurance groups (GKV) have reacted with dismay to suggestions by German Cancer Society (DKG) that the government's disease management programme (DMP) for breast cancer is inadequate. "It is incomprehensible that this professional body is trying to distance itself from a programme which it helped develop only a few weeks ago," said the GKV. Rolf Kreienberg, who was president of the society at the time of the DMP's creation, was instrumental in defining the contents of the programme, it added.